FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/12/030121 [Registered on: 30/12/2020] Trial Registered Prospectively
Last Modified On: 29/12/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   comparative study of use of intraperitoneal drugs ( local anesthetics and adjuvants) for postoperative pain management after laparoscopic surgeries. 
Scientific Title of Study   comparative study of efficacy of intraperitoneal instillation of 0.2% ropivacaine with dexmedetomidine versus 0.2% ropivacaine with ketamine in laparoscopic surgeries - a randomized study 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DUDYALA DHATRI 
Designation  POST GRADUATE TRAINEE 
Affiliation  KALINGA INSTITUTE OF MEDICAL SCIENCES 
Address  DEPARTMENT OF ANESTHESIOLOGY,KALINGA INSTITUTE OF MEDICAL SCIENCES,CAMPUS 5,BHUBANESHWAR

Khordha
ORISSA
751024
India 
Phone  9550801246  
Fax    
Email  2087031@kims.ac.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr AMRITA PANDA 
Designation  Associate professor 
Affiliation  KALINGA INSTITUTE OF MEDICAL SCIENCES 
Address  Department of Anesthesiology,kalinga institute of medical sciences,campus 5,patia,bhubaneshwar,khordha

Khordha
ORISSA
751024
India 
Phone  9439862335  
Fax    
Email  amritapanda1323@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DUDYALA DHATRI 
Designation  POST GRADUATE TRAINEE 
Affiliation  KALINGA INSTITUTE OF MEDICAL SCIENCES 
Address  Dept of Anesthesiology,kalinga institute of medical sciences,campus 5,patia,bhubaneshwar,khordha

Khordha
ORISSA
751024
India 
Phone  9550801246  
Fax    
Email  2087031@kims.ac.in  
 
Source of Monetary or Material Support  
Kalinga institute of medical sciences 
 
Primary Sponsor  
Name  DUDYALA DHATRI 
Address  kims girls hostel,block b,campus 5, patia,bhuabneshwar,khordha orissa 751024 
Type of Sponsor  Other [] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DUDYALA DHATRI  kalinga institue of medical sciences  Department of Anesthesiology
Khordha
ORISSA 
9550801246

2087031@kims.ac.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K811||Chronic cholecystitis, (2) ICD-10 Condition: K800||Calculus of gallbladder with acutecholecystitis, (3) ICD-10 Condition: K802||Calculus of gallbladder without cholecystitis, (4) ICD-10 Condition: K35||Acute appendicitis, (5) ICD-10 Condition: N832||Other and unspecified ovarian cysts,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  intraperitoneal instillation in laparoscopic surgeries  two adjuvants added to local anesthetics will be compared in terms of postoperative pain 
Intervention  intraperitoneal instillation of local anesthetic with adjuvant  local anesthetic along with adjuvants will be instilled intraperitoneally in laparoscopic surgeries for postoperative pain management Patients in Group I will receive 30ml of 0.2% Ropivacaine with dexmedetomidine 0.5μg/kg (titrated to 1ml) Patients in Group II will receive 30ml of 0.2% Ropivacaine with ketamine 0.5mg/kg (titrated to 1ml) Patients in Group III will receive 30ml 0.2% Ropivacaine with normal saline (1ml). Visual analogue score will be assessed for 24 hours 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  PATIENTS WITH ASA PS I & II POSTED FOR ELECTIVE LAPAROSCOPIC SURGERIES 
 
ExclusionCriteria 
Details  Patient refusal
Local anesthetic allergy / drug allergy
Pregnancy
Patients with Cardiovascular/Respiratory/ Liver/ Renal diseases
BMI ≥ 30 Kg/m2
If any other surgeries combined in the same sitting
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To study the total duration of analgesia and total rescue analgesic dose requirements in first 24 hours post operatively.  for every 30 min for first two hours and then at 6 hours,12 hours and 24 hours. 
 
Secondary Outcome  
Outcome  TimePoints 
The hemodynamic parameters intraoperatively and postoperatively.
Incidence of postoperative nausea and vomiting using Likert scale.
Depth of sedation using Ramsay sedation score.
Incidence of shoulder tip pain using VAS.
 
for every 30 min for first two hours and then at 6 hours,12 hours and 24 hours. 
 
Target Sample Size   Total Sample Size="105"
Sample Size from India="105" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   01/01/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Postoperative pain management in laparoscopic surgeries plays a very crucial role in Enhanced Recovery After Surgery. Intraperitoneal instillation of local anesthetic will block the free nerve endings in the peritoneum and thus provide relief from visceral pain.
In this study one group will receive 0.2 % Ropivacaine (30ml) with 0.5mcg/kg Dexmedetomidine (1ml) and other group will receive 0.2 % Ropivacaine (30ml) with 0.5mg/kg Ketamine (1ml). Control group will receive 0.2 % Ropivacaine (30ml) with normal saline (1ml).Three groups will be compared in terms of intensity of static and dynamic pain by VAS score for first 24 hours postoperatively. The total duration of analgesia and total analgesic dose will be compared in three groups.

 
Close